ANI Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own ANI Pharmaceuticals Inc.
iShares Core S&P Small Cap ETF
512,230
4.33%
144
0.06%
09/06/2018
Vanguard Total Stock Market Index Fund
205,095
1.74%
0
0%
07/31/2018
iShares Russell 2000 ETF
166,019
1.41%
-90
0.02%
09/06/2018
DFA US Small Cap Portfolio
162,437
1.37%
9,046
0.04%
04/30/2018
iShares S&P Small Cap 600 Growth ETF
157,452
1.33%
226
0.13%
09/06/2018
iShares Nasdaq Biotechnology ETF
137,073
1.15%
-1,785
0.08%
09/06/2018
Vanguard Extended Market Index Fund
120,700
1.02%
1,100
0.01%
07/31/2018
PowerShares S&P Small Cap Health Care Portfolio
104,317
0.88%
6,633
0.49%
09/05/2018
Vanguard Tax Managed Small Cap Fund
86,074
0.73%
2,500
0.07%
07/31/2018
iShares Russell 2000 Growth ETF
81,524
0.69%
0
0.04%
09/06/2018
| Address |
210 Main Street West
Baudette Minnesota 56623
United States
|
|
Employees
|
- |
| Website |
http://www.anipharmaceuticals.com |
| Updated |
07/08/2019 |
| ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN. |
